Global Prefillable Glass Syringes Market Insights and Forecast to 2028

Market Analysis and Insights: Global Prefillable Glass Syringes Market
Due to the COVID-19 pandemic, the global Prefillable Glass Syringes market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, With Needle accounting for % of the Prefillable Glass Syringes global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Small Molecules Injection segment is altered to an % CAGR throughout this forecast period.
China Prefillable Glass Syringes market size is valued at US$ million in 2021, while the US and Europe Prefillable Glass Syringes are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prefillable Glass Syringes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Prefillable Glass Syringes include SCHOTT AG, Nipro, Gerresheimer, BD, Stevanato Group, West Pharma, Baxter, Shandong Weigao and Shandong Pharmaceutical Glass and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Prefillable Glass Syringes Scope and Segment
Prefillable Glass Syringes market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Prefillable Glass Syringes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
With Needle
Without Needle

Segment by Application
Small Molecules Injection
Large Molecules Injection

By Company
SCHOTT AG
Nipro
Gerresheimer
BD
Stevanato Group
West Pharma
Baxter
Shandong Weigao
Shandong Pharmaceutical Glass
Ningbo Zheng Li

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE